Anastrozole versus tamoxifen as first-line therapy for advanced breast cancer in 668 postmenopausal women: results of the tamoxifen or arimidex randomized group efficacy and tolerability study

Nom du journal : J Clin Oncol

Année : 2000

Volume : 18

Page de départ : 3748

Page de fin : 3757

Auteurs: Bonneterre J, Thürlimann B, Robertson J, Krzakowski M, Mauriac L, Koralewski P, Vergote I, Webster A, Steinberg M, von Euler M, for the Arimidex Study Group, for the Arimidex Study Group,